Timo D Müller Selected Research

Dimethylphenylpiperazinium Iodide

1/2020	Pharmacological targeting of α3β4 nicotinic receptors improves peripheral insulin sensitivity in mice with diet-induced obesity.
10/2018	Coordinated targeting of cold and nicotinic receptors synergistically improves obesity and type 2 diabetes.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Timo D Müller Research Topics

Disease

45	Obesity 01/2022 - 09/2008
34	Body Weight (Weight, Body) 01/2022 - 12/2010
13	Type 2 Diabetes Mellitus (MODY) 01/2022 - 01/2016
11	Insulin Resistance 01/2021 - 10/2013
11	Weight Loss (Weight Reduction) 01/2019 - 09/2008
10	Glucose Intolerance 10/2018 - 10/2012
8	Metabolic Diseases (Metabolic Disease) 07/2022 - 06/2012
5	Inflammation (Inflammations) 01/2021 - 09/2014
4	Starvation 01/2021 - 01/2009
4	Weight Gain 01/2020 - 01/2009
4	Dyslipidemias (Dyslipidemia) 01/2020 - 12/2012
4	Neoplasms (Cancer) 01/2018 - 10/2015
4	Metabolic Syndrome (Dysmetabolic Syndrome X) 04/2017 - 12/2012
4	Cachexia 04/2017 - 12/2010
3	Hypoglycemia (Reactive Hypoglycemia) 01/2021 - 05/2011
3	Hyperphagia (Overeating) 01/2020 - 11/2012
3	Anorexia Nervosa 01/2013 - 01/2009
2	Atherosclerosis 01/2021 - 10/2016
2	Non-alcoholic Fatty Liver Disease 01/2021 - 01/2019
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2020 - 10/2016
2	Fatty Liver 01/2020 - 10/2016
2	Ketosis 10/2015 - 01/2011
2	Hyperglycemia 05/2013 - 12/2012
1	AIDS-Related Complex (ARC) 11/2022
1	Acute Erythroblastic Leukemia (Erythroleukemia) 07/2022
1	Hypoxia (Hypoxemia) 01/2021
1	Lipodystrophy 01/2021
1	Allan-Herndon-Dudley syndrome 06/2020
1	Prader-Willi Syndrome (Syndrome, Prader-Willi) 01/2020
1	Fibrosis (Cirrhosis) 01/2019
1	Liver Diseases (Liver Disease) 01/2019
1	Lipoma (Lipomata) 01/2018

Drug/Important Bio-Agent (IBA)

27	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 09/2008
15	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2022 - 12/2012
10	Hormones (Hormone)IBA 01/2022 - 12/2010
10	Peptides (Polypeptides)IBA 01/2021 - 06/2012
9	GhrelinIBA 01/2018 - 12/2010
8	CholesterolIBA 01/2020 - 09/2008
6	Glucagon (Glukagon)FDA Link 01/2021 - 05/2013
6	Insulin (Novolin)FDA Link 01/2021 - 10/2012
6	fibroblast growth factor 21IBA 01/2020 - 06/2012
5	LeptinIBA 01/2021 - 01/2009
4	IncretinsIBA 01/2022 - 10/2013
4	LipidsIBA 01/2020 - 11/2012
4	Triglycerides (Triacylglycerol)IBA 01/2020 - 09/2008
4	Proteins (Proteins, Gene)FDA Link 01/2019 - 01/2011
4	Pharmaceutical PreparationsIBA 01/2019 - 12/2010
3	MicellesIBA 07/2022 - 01/2020
3	Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA 01/2020 - 10/2018
3	Ghrelin ReceptorsIBA 01/2014 - 05/2011
3	AcyltransferasesIBA 10/2012 - 05/2011
2	Blood Proteins (Serum Proteins)IBA 03/2021 - 01/2021
2	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2019
2	Dual-Specificity PhosphatasesIBA 11/2020 - 01/2017
2	Thyroid HormonesIBA 06/2020 - 10/2016
2	Dimethylphenylpiperazinium IodideIBA 01/2020 - 10/2018
2	Peptide Hormones (Polypeptide Hormones)IBA 01/2018 - 05/2011
2	Glucagon Receptors (Glucagon Receptor)IBA 10/2017 - 01/2015
2	EnzymesIBA 10/2016 - 10/2012
2	Blood Glucose (Blood Sugar)IBA 01/2016 - 09/2008
2	setmelanotideIBA 01/2016 - 03/2015
2	Type 4 Melanocortin Receptor (Melanocortin-4 Receptor)IBA 01/2016 - 03/2015
2	CarbohydratesIBA 10/2015 - 01/2011
2	Fatty Acids (Saturated Fatty Acids)IBA 10/2015 - 10/2012
2	Exenatide (Byetta)FDA Link 04/2014 - 06/2012
2	Dietary Fats (Dietary Fat)IBA 04/2014 - 01/2011
2	salicylhydroxamic acid (SHAM)IBA 02/2014 - 09/2013
1	Aldehyde Dehydrogenase 1 FamilyIBA 11/2022
1	Glial Fibrillary Acidic ProteinIBA 11/2022
1	SugarsIBA 11/2022
1	CyclodextrinsIBA 07/2022
1	mannosamine (D-mannosamine)IBA 07/2022
1	Membrane Proteins (Integral Membrane Proteins)IBA 10/2021
1	IntegrinsIBA 01/2021
1	Insulin ReceptorIBA 01/2021
1	GlycogenIBA 01/2021
1	Endothelial Growth FactorsIBA 01/2021
1	Phosphates (Orthophosphate)IBA 01/2021
1	gastric inhibitory polypeptide receptorIBA 01/2021
1	Corticotropin-Releasing HormoneIBA 11/2020
1	Mitogen-Activated Protein KinasesIBA 11/2020
1	RimonabantIBA 02/2020
1	Glucagon-Like Peptide-1 Receptor AgonistsIBA 01/2020
1	Detergents (Detergent)IBA 01/2020
1	Epinephrine (Adrenaline)FDA LinkGeneric 01/2020
1	glycoprotein phospholipase DIBA 01/2020
1	Alkaline PhosphataseIBA 01/2020
1	Lipoproteins (Lipoprotein)IBA 01/2020
1	Metformin (Glucophage)FDA LinkGeneric 12/2019
1	Polymeric Immunoglobulin Receptors (Polymeric Immunoglobulin Receptor)IBA 01/2019
1	ProteomeIBA 01/2019
1	Apolipoproteins E (ApoE)IBA 01/2019
1	icilinIBA 10/2018
1	Nonesterified Fatty Acids (NEFA)IBA 10/2018

Therapy/Procedure

17	Therapeutics 07/2022 - 06/2012
6	Drug Therapy (Chemotherapy) 01/2022 - 09/2013
6	Bariatric Surgery 01/2019 - 09/2013
2	Glycemic Control 03/2015 - 01/2015
2	Gastric Bypass (Roux-en-Y Gastric Bypass) 02/2014 - 09/2013
2	Caloric Restriction 11/2012 - 06/2012